dpp4 and glp 1 used together Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

This analysis in #JCOOP showed a nearly 30% drop in incidencefrom 2.3% to 1.6% and it has generated a lot of discussion

5-Panel

I reluctantly went for Week 4 and it broke me.Food began to depress me which is a really bad place to be

America's First Chef-to-You Meal Delivery: healthy eating, weight loss, GLP-1 balanced meals, or delicious food

GLP1R-positive medullary thyroid carcinomas and all benign insulinomas are candidates for in vivo GLP1R targeting.